Literature DB >> 7530384

Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis.

H Humphreys1, D Peckham, P Patel, A Knox.   

Abstract

BACKGROUND: Burkholderia (Pseudomonas) cepacia is an increasingly important pathogen in patients with cystic fibrosis but it is unclear how it spreads from patient to patient. A study was undertaken to determine whether B cepacia could be recovered from room air occupied by colonised adult patients with cystic fibrosis.
METHODS: Air samples were obtained consecutively from an enclosed room or isolation cubicle before, during, and after occupation by six patients on nine occasions using a surface air sampler incorporating contact plates with selective medium. Settle plates were also used and sputum from five patients was cultured.
RESULTS: B cepacia was recovered from room air during occupation by five of six patients, the number of bacteria ranging from 1 to 158 cfu/m3 (mean 32 cfu/m3). The number of bacteria isolated was greater when patients were coughing. B cepacia persisted in room air on four occasions after the patient left the room, on one occasion for up to 45 minutes.
CONCLUSIONS: The isolation of B cepacia from the air of rooms occupied by colonised patients suggests that dissemination might occur by aerosol as well as by direct physical contact with patients or contaminated environmental sites.

Entities:  

Mesh:

Year:  1994        PMID: 7530384      PMCID: PMC475280          DOI: 10.1136/thx.49.11.1157

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  11 in total

1.  Microbes in the air--when to count! (the role of air sampling in hospitals)

Authors:  H Humphreys
Journal:  J Med Microbiol       Date:  1992-08       Impact factor: 2.472

2.  Pseudomonas cepacia in inpatients with cystic fibrosis.

Authors:  J W Nelson; C J Doherty; P H Brown; A P Greening; M E Kaufmann; J R Govan
Journal:  Lancet       Date:  1991-12-14       Impact factor: 79.321

3.  Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications.

Authors:  S Walters; E G Smith
Journal:  Lancet       Date:  1993-07-03       Impact factor: 79.321

4.  Performance of the surface air system air samplers.

Authors:  V Lach
Journal:  J Hosp Infect       Date:  1985-03       Impact factor: 3.926

Review 5.  The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.

Authors:  O C Tablan; W J Martone; W R Jarvis
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

6.  Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis.

Authors:  M J Thomassen; C A Demko; C F Doershuk; R C Stern; J D Klinger
Journal:  Am Rev Respir Dis       Date:  1986-10

7.  Case-control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis.

Authors:  D R Burdge; E M Nakielna; M A Noble
Journal:  Infect Control Hosp Epidemiol       Date:  1993-03       Impact factor: 3.254

8.  Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov.

Authors:  E Yabuuchi; Y Kosako; H Oyaizu; I Yano; H Hotta; Y Hashimoto; T Ezaki; M Arakawa
Journal:  Microbiol Immunol       Date:  1992       Impact factor: 1.955

9.  Controlled study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis.

Authors:  G Gladman; P J Connor; R F Williams; T J David
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

10.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis.

Authors:  J J LiPuma; S E Dasen; D W Nielson; R C Stern; T L Stull
Journal:  Lancet       Date:  1990-11-03       Impact factor: 79.321

View more
  10 in total

1.  Environmental sampling to detect Burkholderia cepacia in a cystic fibrosis outpatient clinic.

Authors:  H Humphreys; D Peckhman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

Review 2.  A scoping review on bio-aerosols in healthcare and the dental environment.

Authors:  Charifa Zemouri; Hans de Soet; Wim Crielaard; Alexa Laheij
Journal:  PLoS One       Date:  2017-05-22       Impact factor: 3.240

3.  Transmissibility and infection control implications of Burkholderia cepacia in cystic fibrosis.

Authors:  S K Fung; H Dick; H Devlin; E Tullis
Journal:  Can J Infect Dis       Date:  1998-05

Review 4.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

Review 5.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

6.  Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.

Authors:  M L Whiteford; J D Wilkinson; J H McColl; F M Conlon; J R Michie; T J Evans; J Y Paton
Journal:  Thorax       Date:  1995-11       Impact factor: 9.139

7.  Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.

Authors:  K Muhdi; F P Edenborough; L Gumery; S O'Hickey; E G Smith; D L Smith; D E Stableforth
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

8.  Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.

Authors:  M McCloskey; J McCaughan; A O Redmond; J S Elborn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

9.  Evaluation of four sampling devices for Burkholderia pseudomallei laboratory aerosol studies.

Authors:  Michael Schuit; Sierra Gardner; Jill Taylor; Paul Dabisch
Journal:  PLoS Negl Trop Dis       Date:  2021-02-01

10.  A laminar flow model of aerosol survival of epidemic and non-epidemic strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis.

Authors:  Ian J Clifton; Louise A Fletcher; Clive B Beggs; Miles Denton; Daniel G Peckham
Journal:  BMC Microbiol       Date:  2008-06-26       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.